Philippine Passport Stands Out Globally For Its Unique Aesthetic

Ipinagmamalaki ng Pilipinas ang kanyang maroon na pasaporte, tampok ang agila na simbolo ng ating lakas at kalayaan.

DHSUD Marks PBBM’s 1000th Day With 4PH Project Inspection

Bilang paggunita sa 1000th araw ni Pangulong Marcos Jr., pinuntahan ng DHSUD ang proyekto ng Bocaue Bulacan Manor sa ilalim ng 4PH.

Batanes Urged To Follow Bhutan-Inspired Low-Impact, High-Value Tourism

Sa pamamagitan ng Bhutan-inspired tourism, maaring maging world-class ang Batanes habang pinapangalagaan ang kalikasan.

Senator Bats For Stronger French-Philippines Ties On Sustainable Blue Economy

Senador Loren Legarda, nagpahayag ng suporta sa pakikipagtulungan ng Pilipinas at France para sa isang sustainable blue economy.

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.
By The Philippine Post

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

0
0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.

The Phase 1a study will involve 16 volunteers in total, and the researchers will determine the maximum tolerable dose for patients, while the Phase 1b study will focus on the medication’s efficacy and safety in 10 other patients.

Rana Nomak Sanyal, a chemistry professor at Bogazici University, and her team have developed the medicine.

Fevzi Altuntas, who is in charge of the Phase 1a research at Ankara Oncology Training and Research Hospital, told Anadolu Agency that scientists are working together to ensure that Turkiye has self-sufficiency in health to the level where it can develop its own medicines.

“The drug will be a beacon of hope for people with lung cancer. A new molecule, a targeted agent,” he said, adding that patients who tried standard treatments without success could benefit from the cure.

Altuntas added the hospital’s Clinical Research Center has taken on significant responsibilities at both the national and international levels.

He highlighted that the research center has conducted a number of studies, including 114 international Phase 2 and Phase 3 studies, a national virus-like particle (VLP) vaccine, Car-T-cell therapy, and seven Phase 1 cancer trials. (PNA)